Acrivon Therapeutics Cash from Financing (TTM) Analysis

Acrivon Therapeutics Inc (ACRV)

9.05 +0.49 (+5.72%) USD | NASDAQ | May 20, 13:04

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2022. Upgrade now.

Date	Value
March 31, 2024	-1.726M
December 31, 2023	-1.554M
September 30, 2023	102.32M

Date	Value
June 30, 2023	102.10M
March 31, 2023	101.71M
December 31, 2022	101.71M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.726M

Minimum

Mar 2024

102.32M

Maximum

Sep 2023

67.43M

Average

101.71M

Median

Dec 2022

Cash from Financing (TTM) Benchmarks